Supplemental Table 1 A deficiency screen of the main autosomes for dominant modification of the CLN3 overexpression phenotype in the eye. Five regions of the genome that contain dominant enhancers of the phenotype were identified and four regions that contain dominant suppressors.
Supplemental Figure S1
Alignment of the protein sequences of human and Drosophila CLN3. Identity is displayed in yellow and similarity in green. The topology is based on the prediction for the human CLN3 protein in Ref 22. Predicted intracellular and extracellular domains are shown with black dashed lines below and red dashed lines above the sequences respectively. Transmembrane domains are boxed and the predicted amphipathic helix is bracketed (*). The experimentally determined lysosomal targeting sequences in the third and last intracellular loops are displayed in a dashed red box and are conserved in the Drosophila protein. Potential glycosylation sites in the human protein are shown in blue but are not conserved. Particularly strong conservation is shown in the second lumenal loop, in the Cterminal intracellular domain and in the transmembrane domains.
Supplemental Figure S2
Ubiquitous overexpression of CLN3 leads to a reduction in adult size. Two examples are shown with control flies to the left. Genotypes are CyO/+;daGal4/+ (control) and UAS-CLN3/+;daGal4/+ (overexpression, denoted da>CLN3). The mass of the smaller flies is approximately 50% of controls.
Supplemental Figure S3
Truncated forms of CLN3 fail to localise correctly. C-terminally truncated forms of human (A) and Drosophila (B) CLN3 were fused to GFP and expressed in HEK293 cells. The truncation is designed to mimic the truncated form of CLN3 that may be expressed in patients carrying the common 1 kb deletion mutation of CLN3. Both truncated proteins displayed a reticular distribution indicating a failure to transit through the Endoplasmic Reticulum. Neither protein co-localised with LAMP1.
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